(Q48703896)

14 February 2018

title

Characteristics of late-onset myasthenia gravis. (English)

1 reference

14 February 2018

0 references

Saša A Zivković

1

1 reference

14 February 2018

Paula R Clemens

series ordinal

2

1 reference

14 February 2018

David Lacomis

series ordinal

3

1 reference

14 February 2018

publication date

5 April 2012

1 reference

14 February 2018

published in

Journal of Neurology

1 reference

14 February 2018

volume

259

1 reference

14 February 2018

issue

10

1 reference

14 February 2018

page(s)

2167-2171

1 reference

14 February 2018

https://scigraph.springernature.com/pub.10.1007/s00415-012-6478-6

exact match

0 references

cites work

Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Evidence of underdiagnosis of myasthenia gravis in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Myasthenia gravis: a higher than expected incidence in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Myasthenia gravis in the elderly: Is it different?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Epidemiologic evidence for a changing natural history of myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

The relationship of age to outcome in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

The epidemiology of myasthenia gravis in central and western Virginia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Myasthenia gravis and elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Lifetime course of myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Myasthenia gravis in Ceará, Brazil: clinical and epidemiological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Myasthenia gravis (MG): epidemiological data and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Myasthenia gravis: a study from India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Clinical and serological study of myasthenia gravis in HuBei Province, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Maintenance of immune tolerance to a neo-self acetylcholine receptor antigen with aging: implications for late-onset autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Plasma exchange in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6478-6

Safety of intravenous immunoglobulin treatment

21 January 2018

1 reference

12 December 2020

Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey

1 reference

12 December 2020

Late-onset myasthenia gravis. Follow-up of 113 patients diagnosed after age 60

1 reference

12 December 2020

Late-onset myasthenia gravis: a changing scene

1 reference

12 December 2020

Myasthenia gravis in the tenth decade

1 reference

12 December 2020

Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation

1 reference

12 December 2020

10.1007/S00415-012-6478-6

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018